Answers are grounded in this paper and cite their sources.
The treatment results compare favorably to published outcomes from similar cohorts using 3-dimensional conformal CRT. The observed patterns of failure support the current UK IMRT voluming guidelines and dose levels, highlighting our prophylactic nodal dose as sufficient to prevent isolated regional relapse in uninvolved nodes. Further investigation of strategies to optimize CR should remain a priority in ASCC because the site of primary disease remains the overwhelming site of relapse.
No takes yet. Share an insight, caveat, or question.
Shakir et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: